Concepedia

Hsp90 inhibitors cause G2/M arrest associated with the reduction of Cdc25C and Cdc2 in lung cancer cell lines

Megumi Senju, Naoko Sueoka, Akemi Sato, Kentaro Iwanaga, Yukinori Sakao, Shinji Tomimitsu, Masaki Tominaga, Koji Irie, Shinichiro Hayashi, Eisaburo Sueoka

Journal of Cancer Research and Clinical Oncology · 2005 · 71 citations · 33 references

DOIFull text

Open access

Concepts

References

33

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella et al. · New England Journal of Medicine · 2004 · 11.5K citations

, , +16

Revisions in the International System for Staging Lung Cancer

Clifton F. Mountain · CHEST Journal · 1997 · 4.6K citations

, , +13

High Performance of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography and Contrast-Enhanced CT in a Rapid Outpatient Diagnostic Program for Patients with Suspected Lung Cancer

Pepijn Brocken, P.N.R. Dekhuijzen, Liesbeth Peters-Bax et al. · Respiration · 2013 · 4K citations · Full text

, , +11

Gefitinib-Sensitizing <i>EGFR</i> Mutations in Lung Cancer Activate Anti-Apoptotic Pathways

Raffaella Sordella, Daphne W. Bell, Daniel A. Haber et al. · Science · 2004 · 1.6K citations

, , +17

A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors

Adeela Kamal, Lia Thao, John Sensintaffar et al. · Nature · 2003 · 1.4K citations

, , +10